Heat­ed oral ar­gu­ments at SCO­TUS hint at Sanofi-Re­gen­eron edge over Am­gen in patent spat

WASH­ING­TON — Lawyers for Sanofi-Re­gen­eron, Am­gen, and the fed­er­al gov­ern­ment took the stage at the Supreme Court on Mon­day, ar­gu­ing a com­pli­cat­ed patent case over the two sides’ com­pet­ing, block­buster PC­SK9 in­hibitors with jus­tices’ ques­tions hint­ing at a de­ci­sion that will like­ly be a win for Sanofi and Re­gen­eron.

The morn­ing opened with about 45 min­utes for Am­gen’s lawyer, Jef­frey Lamken, who was pep­pered with straight­for­ward ques­tions from As­so­ciate Jus­tices Clarence Thomas and So­nia So­tomay­or, with Thomas at one point ask­ing, “I’m con­fused as to what your in­ven­tion is?”

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN